Archive for the ‘CIMAP’ Category
The Council for Scientific and Industrial Research (CSIR) today launched the country’s first anti-diabetic ayurvedic drug for type two Diabetes mellitus.
The drug BGR-34 is developed jointly by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), the Lucknow-based research units of CSIR.
Launching the drug at a function here, Senior Principal Scientist, CSIR-NBRI, Dr A K S Rawat said, “Six crore adult Indian population has been found to be diabetic and there is no effective solution for diabetes as yet…
New Delhi, Jan 31 (PTI) Union Minister Harsh Vardhan today urged farmers and entrepreneurs to adopt improved technologies for cultivation of better varieties of medicinal and aromatic plants to raise their income.
Speaking at a Kisan Mela (farmers fair) organized at CSIR-Institute of Medicinal and Aromatic Plants CSIR-CIMAP in Lucknow, he said this would also help in production of quality raw material demanded by user industries.
Stating that medicinal and aromatic plants are the “valuable green wealth” of the country, he said these should be sustainably used for creating livelihood opportunities of poor people residing in rural areas….
LUKNOW: Stating that initiatives like Startup India are not merely slogans, Union minister for science & technology and earth sciences Dr Harsh Vardhan on Sunday said, “Today’s economy is idea-driven, and it is the innovation co-efficient is the order of the day. In the department of bio-technology alone, 300 industries and nearly 150 entrepreneurs got support.”
The Union minister, who was in CIMAP (Central Institute of Medicinal and Aromatic Plants – an institution under the Council of Scientific and Industrial Research), to inaugurate the annual Kisan Mela also pointed towards the dynamic change being brought in the working of CSIR labs. He said, “CSIR has formed clusters of laboratories. Some of the clusters formed so far include chemical, biological, physical and strategic. The clusters have been formed to guarantee perfect and effective co-ordination among the laboratories.”…
23 November 2015
COIMBATORE: Lucknow-based Central Institute of Medicinal and Aromatic Plants (CIMAP) is keen on sharing its laboratory facilities available in Lucknow and Bengaluru for the post-graduate students of Tamil Nadu Agricultural University (TNAU) here to work on natural compounds.
The offer was made by CIMAP Director Dr A K Tripathi during his visit to TNAU yesterday…
21 November 2015
LUCKNOW: The Central Institute of Medicinal and Aromatic Plants (CIMAP) in Lucknow had been working extensively on an anti-malaria drug, Artimisinin, for the past two-and-a-half decades. Last month, it was China that got the Nobel Prize for the drug invention.
A.K. Singh, ex-chief scientist and consultant (technology and business development), CIMAP, said that despite being awarded twice by the Council of Scientific and Industrial Research (CSIR) for its research and development work on an anti-malarial drug, Artimisinin, CIMAP missed the international recognition…
20 November 2015
LUCKNOW: Central Institute of Medicinal and Aromatic Plants (CIMAP)’s loss was China’s gain. Anti-malaria drug artemisinin, for which China bagged the Nobel Prize last month, is what Lucknow-based CIMAP has extensively worked on since 1980s. But despite being awarded twice by the Council of Scientific and Industrial Research (CSIR) for its research-and-development work on an anti-malarial drug, artemisinin, CIMAP missed the international recognition…
The old Indo-Chinese rivalry is coursing through the Indian scientific establishment ever since China’s Tu Youyou bagged the Nobel for medicine earlier this month. After her recognition for discovering the anti-malarial artemisinin, there’s a growing sense that the Nobel committee may have overlooked the work of Indian scientists in the same field. Letters are flying thick and fast, as China’s first Nobel for science has become an occasion for Indian scientists to draw attention to their own work on the anti-malarial drug and draw credit they rarely get.
Some scientists even argue that malarial research in India rivals Chinese achievements on “scientific principles”—in the sense that it was done according to globally accepted scientific practice in methodology and publication. Others say Tu’s work was based on traditional knowledge so no single person can be credited for it. Implicit in this is the charge that China has been making a stronger case for its researchers in world fora, pushing in the right places to win them awards, while Indian efforts remain unknown.
R.S. Thakur, 84, a scientist who worked on artemisinin in the government’s labs in the 1980s, believes this work deserves at least as much acknowledgement from the Nobel committee as Tu’s. He says Tu’s discovery was during the ‘Cultural Revolution’, and true to that period, the work was published only in China and remained isolated from international peer review and criticism. “China’s isolation at that time raises questions on the research’s scientific merit. One wonders if certain practices of Tu—such as testing the initial compound on herself—pass the Nobel standards for ethics,” says Dr Thakur, who retired as a director of the Central Institute for Medicinal and Aromatic Plants (CIMAP), Lucknow…..